MetaCap

Merit Medical Systems Inc. (MMSI)

NASDAQ: MMSIHealth CareMedical/Dental InstrumentsUSD

84.34-0.07 (-0.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MMSI stock chart

Technical analysis

Key statistics

All statistics
52-week range
59.74 – 94.85
Day range
83.89 – 86.20
Volume / Avg
560.27K / 656.91K
Beta
—

52-week range

$59.74$94.85

MMSI stock today

On Nov 20, MMSI ended the session at $84.34, shedding $0.07 (0.08%), versus the S&P 500's 3.70% decline. At this level, MMSI sits in the middle of its 52-week range of $59.74 to $94.85: 11.1% below the high, set on Oct 26, 2026 and 41.2% above the low. MMSI is down 4.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 3.3%.

At 31.6x trailing earnings, Merit Medical Systems trades below the peer-group median of 61.4x. Its forward P/E of 18.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Merit Medical Systems

Company profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy.

Industry
Medical/Dental Instruments
CEO
Ms. Martha Goldberg Aronson
Headquarters
South Jordan, UT
Employees
7,500
Website
merit.com

Financial highlights

Full financials

In fiscal 2025, Merit Medical Systems generated $1.52 billion in revenue, up 11.8% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $128.5 million (+6.8% year over year), for a net margin of 8.5% versus a median of 6.5% in the prior 5 years. Gross margin was 48.7% (up from 47.4%) and operating margin 12.2%.

Merit Medical Systems annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.52B$1.36B$1.26B$1.15B$1.07B
Growth+11.75%+7.89%+9.24%+7.09%+11.50%
Net income$128.49M$120.36M$94.41M$74.52M$48.45M
EPS (diluted)$2.13$2.03$1.62$1.29$0.84

Analyst forecast

Forecast

Consensus (12 analysts)

buy

Avg. price target

$107.00+26.87%

  • Strong buy 5
  • Buy 4
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $90.00High $123.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$0.70 vs $0.93
Surprise
-24.73%

MMSI news

All MMSI news

Merit Medical Systems peers

Health Care sector
MMSI peer companies
CompanyPrice% ChgMarket capCompare
HAEHaemonetics Corporation120.16-0.17%$5.47Bvs MMSI
MMEDMiniMed Group Inc.16.01-1.54%$4.50Bvs MMSI
ICUIICU Medical Inc.172.52-1.84%$4.31Bvs MMSI
STVNStevanato Group S.p.A.15.65-1.76%$4.27Bvs MMSI
HTFLHeartflow Inc.46.69+4.62%$4.10Bvs MMSI
TFXTeleflex Incorporated161.58-1.11%$6.41Bvs MMSI
NVSTEnvista Holdings Corporation22.91-1.55%$3.67Bvs MMSI
PLSEPulse Biosciences Inc45.55+2.57%$3.35Bvs MMSI

Indexes, lists and sector

Merit Medical Systems stock FAQ

What is Merit Medical Systems's stock price today?

MMSI last traded at $84.34 as of Nov 20, 4:00 PM EST, down 0.08% on the day. Prices are delayed at least 15 minutes.

Does Merit Medical Systems pay a dividend?

No. Merit Medical Systems does not currently pay a regular cash dividend.

What is MMSI's P/E ratio?

MMSI trades at a trailing P/E ratio of 31.59 and a forward P/E of 18.06, compared with a median of 61.4 for its closest peers.

Who is Merit Medical Systems's CEO?

Ms. Martha Goldberg Aronson is the chief executive officer of Merit Medical Systems Inc., which has about 7,500 employees.

Has MMSI ever split its stock?

Yes. The most recent MMSI stock split was a 5-for-4 split on May 6, 2011, one of 6 splits on record.

What is the MMSI 52-week high?

The 52-week high for MMSI is $94.85 and the 52-week low is $59.74. The stock is currently 11.1% below its high.

Compare MMSI